The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Drug-drug interaction (DDI) of darolutamide with cytochrome P450 (CYP) and P-glycoprotein (P-gp) substrates: Results from clinical and in vitro studies.
 
Christian Zurth
Employment - Bayer
Stock and Other Ownership Interests - Bayer
Patents, Royalties, Other Intellectual Property - Patents formulations of Bayer drug substances
 
Kristina Graudenz
Employment - Bayer
 
Karsten Denner
Employment - Bayer
Stock and Other Ownership Interests - Bayer
 
Timo Korjamo
Employment - Orion
 
Robert Fricke
Employment - Bayer
 
Gary Wilkinson
Employment - Bayer
Stock and Other Ownership Interests - Bayer
 
Friedeborg Seitz
No Relationships to Disclose
 
Olaf Prien
Employment - Bayer
Stock and Other Ownership Interests - Bayer